|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 475/04 | |
| A61P 43/00 | |||
| A61P 9/00 | |||
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/24 | |||
| A61P 7/06 |
| (11) | Patento numeris | 2224927 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08781435.6 |
| Europos patento paraiškos padavimo data | 2008-07-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/069319 |
| Data | 2008-07-07 |
| (87) | Numeris | WO 2009/088530 |
| Data | 2009-07-16 |
| (30) | Numeris | Data | Šalis |
| 18735 P | 2008-01-03 | US | |
| 19753 P | 2008-01-08 | US |
| (72) |
KAKKIS, Emil, D., US
|
| (73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
| (54) | PTERIN ANALOG FOR TREATING BH4 RESPONSIVE CONDITION |
| PTERIN ANALOG FOR TREATING BH4 RESPONSIVE CONDITION |